• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.开口右冠状动脉支架内再狭窄的机制和治疗结果。
EuroIntervention. 2023 Aug 7;19(5):e383-e393. doi: 10.4244/EIJ-D-23-00107.
2
Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.药物洗脱支架植入治疗右冠状动脉开口病变后支架内再狭窄的独立预测因素。
Int J Cardiol. 2017 Aug 1;240:108-113. doi: 10.1016/j.ijcard.2017.04.083. Epub 2017 Apr 26.
3
Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.左主干-左旋支弯曲角度的动态评估:对成功进行双支架PCI术后左旋支开口处支架内再狭窄的意义
Int J Cardiol. 2023 May 1;378:11-19. doi: 10.1016/j.ijcard.2023.02.030. Epub 2023 Feb 15.
4
Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease.对 403 例无保护左主干病变患者的支架面积进行全面的血管内超声评估及其对再狭窄和不良心脏事件的影响。
Circ Cardiovasc Interv. 2011 Dec 1;4(6):562-9. doi: 10.1161/CIRCINTERVENTIONS.111.964643. Epub 2011 Nov 1.
5
Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry.血管内超声引导下生物雷帕霉素A9洗脱支架治疗右冠状动脉开口病变的疗效:一项多中心注册研究
Cardiovasc Interv Ther. 2018 Oct;33(4):321-327. doi: 10.1007/s12928-017-0487-4. Epub 2017 Sep 19.
6
Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts.血管内超声评估静脉桥血管支架内再狭窄
Am J Cardiol. 2019 Apr 1;123(7):1052-1059. doi: 10.1016/j.amjcard.2018.12.030. Epub 2019 Jan 4.
7
Ostial right coronary artery lesion morphology and outcomes after treatment with drug-eluting stents.药物洗脱支架治疗后开口右冠状动脉病变形态及结果。
EuroIntervention. 2024 Feb 5;20(3):e207-e215. doi: 10.4244/EIJ-D-23-00406.
8
Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.功能显著的支架内再狭窄的预测因素:使用冠状动脉造影、血管内超声和心肌灌注成像的综合分析。
JACC Cardiovasc Imaging. 2013 Nov;6(11):1183-90. doi: 10.1016/j.jcmg.2013.09.006.
9
The frequency and clinical characteristics of in-stent restenosis due to calcified nodule development after coronary stent implantation.冠状动脉支架置入术后钙化结节发展导致支架内再狭窄的频率及临床特征。
Int J Cardiovasc Imaging. 2021 Jan;37(1):15-23. doi: 10.1007/s10554-020-01952-z. Epub 2020 Jul 30.
10
Potent Stent-Less Procedure Using Rotational Atherectomy and Drug-Coated Balloon to Right Coronary Ostial Lesion.使用旋磨术和药物涂层球囊治疗右冠状动脉开口病变的有效无支架手术
Cardiovasc Revasc Med. 2019 Sep;20(9):822-826. doi: 10.1016/j.carrev.2018.11.019. Epub 2018 Dec 11.

引用本文的文献

1
Age-Related Anatomical Changes in Carotid Artery Stenosis and Its Impact on Postoperative Complications in Stenting and Endarterectomy.颈动脉狭窄的年龄相关解剖学变化及其对支架置入术和动脉内膜切除术术后并发症的影响。
CNS Neurosci Ther. 2025 Jul;31(7):e70527. doi: 10.1111/cns.70527.
2
Intravascular ultrasound assessment of stent edge restenosis mechanisms and treatment outcomes following percutaneous coronary intervention.经皮冠状动脉介入治疗后支架边缘再狭窄机制及治疗结果的血管内超声评估
Sci Rep. 2025 May 10;15(1):16298. doi: 10.1038/s41598-025-01381-9.
3
From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era.从机制到管理:应对药物洗脱支架时代的支架内再狭窄
Curr Cardiol Rep. 2025 Feb 11;27(1):53. doi: 10.1007/s11886-025-02193-z.
4
Management of Stent Underexpansion and Aorto-ostial Lesions.支架扩张不足及主动脉开口病变的处理
Interv Cardiol. 2024 Dec 23;19:e26. doi: 10.15420/icr.2024.10. eCollection 2024.
5
SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions.SCAI关于钙化冠状动脉病变管理的专家共识声明
J Soc Cardiovasc Angiogr Interv. 2024 Jan 31;3(2):101259. doi: 10.1016/j.jscai.2023.101259. eCollection 2024 Feb.
6
The everolimus eluting Synergy Megatron drug-eluting stent platform: Early outcomes from the European Synergy Megatron Implanters' Registry.依维莫司洗脱 Synergy Megatron 药物洗脱支架平台:来自欧洲 Synergy Megatron 植入者注册研究的早期结果。
Catheter Cardiovasc Interv. 2023 Dec;102(7):1222-1228. doi: 10.1002/ccd.30902. Epub 2023 Nov 10.

本文引用的文献

1
Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.腔内碎石术治疗新发病变与支架内再狭窄的中期结果:来自法国 Shock Initiative 的研究结果。
Int J Cardiol. 2022 Oct 15;365:106-111. doi: 10.1016/j.ijcard.2022.07.023. Epub 2022 Jul 21.
2
Stent Expansion Indexes to Predict Clinical Outcomes: An IVUS Substudy From ADAPT-DES.支架扩张指数预测临床结局:来自 ADAPT-DES 的血管内超声亚研究。
JACC Cardiovasc Interv. 2021 Aug 9;14(15):1639-1650. doi: 10.1016/j.jcin.2021.05.019.
3
Eruptive Calcified Nodules as a Potential Mechanism of Acute Coronary Thrombosis and Sudden Death.爆发性钙化结节作为急性冠状动脉血栓形成和猝死的潜在机制。
J Am Coll Cardiol. 2021 Apr 6;77(13):1599-1611. doi: 10.1016/j.jacc.2021.02.016.
4
Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule.归因于钙化结节的急性冠状动脉综合征患者的心脏结局。
Atherosclerosis. 2021 Feb;318:70-75. doi: 10.1016/j.atherosclerosis.2020.11.005. Epub 2020 Nov 11.
5
Formation of Calcified Nodule as a Cause of Early In-Stent Restenosis in Patients Undergoing Dialysis.透析患者钙化结节形成是早期支架内再狭窄的原因。
J Am Heart Assoc. 2020 Oct 20;9(19):e016595. doi: 10.1161/JAHA.120.016595. Epub 2020 Sep 23.
6
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.药物洗脱支架或金属裸支架经皮冠状动脉介入治疗:随机临床试验的系统评价和个体患者数据分析荟萃分析。
Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2.
7
ACC/AATS/AHA/ASE/EACTS/HVS/SCA/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Valve Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.美国心脏病学会适当使用标准专家组、美国胸外科学会、美国心脏协会、美国超声心动图学会、欧洲心血管外科学会、心脏瓣膜学会、心血管麻醉师学会、心血管血管造影和介入学会、心血管计算机断层扫描学会、心血管磁共振学会和胸外科医师学会 2017 年严重主动脉瓣狭窄患者治疗的适当使用标准:报告
J Am Soc Echocardiogr. 2018 Feb;31(2):117-147. doi: 10.1016/j.echo.2017.10.020. Epub 2017 Dec 16.
8
Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry.血管内超声引导下生物雷帕霉素A9洗脱支架治疗右冠状动脉开口病变的疗效:一项多中心注册研究
Cardiovasc Interv Ther. 2018 Oct;33(4):321-327. doi: 10.1007/s12928-017-0487-4. Epub 2017 Sep 19.
9
Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.第二代药物洗脱支架中早期与晚期支架内再狭窄的特点:光学相干断层成像研究。
EuroIntervention. 2017 Jun 20;13(3):294-302. doi: 10.4244/EIJ-D-16-00787.
10
Comparison of early- and new-generation drug-eluting stent implantations for ostial right coronary artery lesions.新一代药物洗脱支架与早期药物洗脱支架植入治疗右冠状动脉开口病变的比较。
Cardiovasc Ther. 2017 Apr;35(2). doi: 10.1111/1755-5922.12247.

开口右冠状动脉支架内再狭窄的机制和治疗结果。

Mechanisms and treatment outcomes of ostial right coronary artery in-stent restenosis.

机构信息

Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.

出版信息

EuroIntervention. 2023 Aug 7;19(5):e383-e393. doi: 10.4244/EIJ-D-23-00107.

DOI:10.4244/EIJ-D-23-00107
PMID:37283548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10397676/
Abstract

BACKGROUND

Despite a high rate of in-stent restenosis (ISR) after stenting the right coronary artery (RCA) ostium, the mechanism of ostial RCA ISR is not well understood.

AIMS

We aimed to clarify the cause of ostial RCA ISR using intravascular ultrasound (IVUS).

METHODS

Overall, 139 ostial RCA ISR lesions were identified with IVUS, pre-revascularisation. Primary ISR mechanisms were classified as follows: 1) neointimal hyperplasia (NIH); 2) neoatherosclerosis; 3) ostium not covered by the stent; 4) stent fracture or deformation; 5) stent underexpansion (old minimum stent area <4.0 mm or stent expansion <50%); or 6) a protruding calcified nodule.

RESULTS

The median duration from prior stenting was 1.2 (first quartile 0.6, third quartile 3.1) years. The primary mechanisms of ISR were NIH in 25% (n=35) of lesions, neoatherosclerosis in 22% (n=30), uncovered ostium in 6% (n=9) (biological cause 53%, n=74), stent fracture or deformation in 25% (n=35), underexpansion in 11% (n=15), and protruding calcified nodules in 11% (n=15) (mechanical cause 47%, n=65). Including secondary mechanisms, 51% (n=71) of ostial RCA ISRs had stent fractures that were associated with greater hinge motion of the ostial-aorta angle during the cardiac cycle. The Kaplan-Meier rate of target lesion failure at 1 year was 11.5%. When the mechanically caused ISRs were treated without new stents, they suffered a higher subsequent event rate (41.4%) compared with non-mechanical causes or mechanical causes treated without restenting (7.8%, unadjusted hazard ratio 6.44, 95% confidence interval: 2.33-17.78; p<0.0001).

CONCLUSIONS

Half of the ostial RCA ISRs were due to mechanical causes. Subsequent event rates were high, especially in mechanically caused ISRs treated without the implantation of a new stent.

摘要

背景

尽管右冠状动脉(RCA)开口支架置入术后的支架内再狭窄(ISR)发生率较高,但 RCA 开口 ISR 的发生机制尚不清楚。

目的

我们旨在通过血管内超声(IVUS)明确 RCA 开口 ISR 的病因。

方法

共 139 例 RCA 开口 ISR 病变在血管重建前接受 IVUS 检查。将原发性 ISR 机制分为以下几类:1)新生内膜增生(NIH);2)新生动脉粥样硬化;3)支架未覆盖开口;4)支架断裂或变形;5)支架扩张不足(旧最小支架面积<4.0mm 或支架扩张<50%);或 6)突出的钙化结节。

结果

支架置入后中位时间为 1.2 年(四分位距 0.63.1 年)。ISR 的主要机制为 NIH(25%,n=35)、新生动脉粥样硬化(22%,n=30)、支架未覆盖开口(6%,n=9)(生物原因 53%,n=74)、支架断裂或变形(25%,n=35)、扩张不足(11%,n=15)和突出的钙化结节(11%,n=15)(机械原因 47%,n=65)。包括次要机制在内,51%(n=71)的 RCA 开口 ISR 支架断裂与心脏周期中 RCA-主动脉夹角的铰链运动较大有关。1 年时靶病变失败的 Kaplan-Meier 发生率为 11.5%。未行新支架置入治疗的机械性 ISR 患者发生后续不良事件的风险更高(41.4%),而非机械性原因或机械性原因且未行再次支架置入治疗的患者(7.8%)(未校正风险比 6.44,95%置信区间:2.3317.78;p<0.0001)。

结论

半数 RCA 开口 ISR 由机械原因引起。尤其是未植入新支架治疗的机械性 ISR 患者,其后续不良事件发生率较高。